RA Capital Nexus Fund II, Director: ARS Pharmaceuticals SPRY Buy · Filed 24/03/27

Trade details

Type: Insider buy
Amount: $4,371,464.75
Shares · price: 457,745 sh · $9.55 a share
Held after: 9,452,119 sh
Stock: ARS Pharmaceuticals SPRY
Person: RA Capital Nexus Fund IIDirector
Trade date: 24/03/26
Filed: 24/03/27
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 5 insiders
Holding change: +5.1%

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/02/25~24/04/25

RA Capital Nexus Fund II's recent trades

RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.1M
87,143 sh
$2.1M
Filed 05/06
Traded 05/05
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06

RA Capital Nexus Fund II, Director — bought $4.4M of ARS Pharmaceuticals SPRY · 457,745 sh @ $9.55 | Whalegun